Semi-Annual Statement Of Income

PhoenixBio Co.,Ltd. - Filing #7297348

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Semi-annual statement of income
Statement of income
Net sales
788,201,000 JPY
881,757,000 JPY
Cost of sales
240,469,000 JPY
311,040,000 JPY
Ordinary profit (loss)
-123,652,000 JPY
45,868,000 JPY
Gross profit (loss)
547,731,000 JPY
570,716,000 JPY
Extraordinary income
JPY
17,285,000 JPY
Selling, general and administrative expenses
646,561,000 JPY
575,801,000 JPY
Extraordinary losses
0 JPY
JPY
Selling, general and administrative expenses
Remuneration for directors (and other officers)
75,793,000 JPY
78,622,000 JPY
Depreciation
4,039,000 JPY
4,111,000 JPY
Profit (loss) before income taxes
-123,652,000 JPY
63,154,000 JPY
Operating profit (loss)
-98,830,000 JPY
-5,084,000 JPY
Non-operating income
4,858,000 JPY
52,158,000 JPY
Income taxes - current
4,077,000 JPY
4,818,000 JPY
Income taxes - deferred
-2,980,000 JPY
30,708,000 JPY
Non-operating income
Interest income
3,778,000 JPY
2,743,000 JPY
Non-operating expenses
29,680,000 JPY
1,205,000 JPY
Income taxes
1,096,000 JPY
35,527,000 JPY
Profit (loss)
-124,748,000 JPY
27,626,000 JPY
Non-operating expenses
Interest expenses
2,599,000 JPY
972,000 JPY
Extraordinary income
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.